Mouse Monoclonal HIF-2-alpha antibody. Suitable for WB and reacts with Human samples. Cited in 7 publications. Immunogen corresponding to Recombinant Fragment Protein within Human EPAS1 aa 550 to C-terminus.
View Alternative Names
BHLHE73, HIF2A, MOP2, PASD2, EPAS1, Endothelial PAS domain-containing protein 1, EPAS-1, Basic-helix-loop-helix-PAS protein MOP2, Class E basic helix-loop-helix protein 73, HIF-1-alpha-like factor, Hypoxia-inducible factor 2-alpha, Member of PAS protein 2, PAS domain-containing protein 2, bHLHe73, HLF, HIF-2-alpha, HIF2-alpha
- WB
Supplier Data
Western blot - Anti-HIF-2-alpha antibody [OTI2G5] (AB157249)
False colour image of Western blot : Anti-HIF-2-alpha antibody [OTI2G5] staining at 1/500 dilution, shown in black; Rabbit Anti-GAPDH antibody [EPR16891] (ab181602) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab157249 was shown to bind specifically to HIF-2-alpha. A band was observed at 100 kDa in treated wild-type A549 cell lysates with no signal observed at this size in EPAS1 knockout cell line ab259774 (knockout cell lysate ab259779). To generate this image, wild-type and EPAS1 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % BSA in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with Optiblot (ECL reagent ab133456) and imaged with 20 seconds exposure time. Secondary antibodies used were HRP conjugated Goat anti-Mouse (H+L) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) at 1/20000 dilution.
All lanes:
Western blot - Anti-HIF-2-alpha antibody [OTI2G5] (ab157249) at 1/500 dilution
Lane 1:
Wild-type A549 Untreated (DFO Control) cell lysate at 20 µg
Lane 2:
Wild-type A549 Treated DFO (1 mM, 24 h) cell lysate at 20 µg
Lane 2:
Western blot - Human EPAS1 (HIF-2-alpha) knockout A549 cell line (<a href='/en-us/products/cell-lines/human-epas1-hif-2-alpha-knockout-a549-cell-line-ab259774'>ab259774</a>)
Lane 3:
EPAS1 knockout A549 Untreated (DFO Control) cell lysate at 20 µg
Lane 4:
EPAS1 knockout A549 Treated DFO (1 mM, 24 h) cell lysate at 20 µg
Predicted band size: 96 kDa
Observed band size: 100 kDa
false
- WB
Unknown
Western blot - Anti-HIF-2-alpha antibody [OTI2G5] (AB157249)
HEK293T cell lysates were generated from transient transfection of the cDNA clone (RC216194)
All lanes:
Western blot - Anti-HIF-2-alpha antibody [OTI2G5] (ab157249) at 1/2000 dilution
Lane 1:
HEK293T cells transfected with pCMV6-ENTRY control at 5 µg
Lane 2:
HEK293T cells transfected with pCMV6-ENTRY HIF2 alpha at 5 µg
Predicted band size: 96 kDa
false
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HIF-2-alpha regulates the expression of genes involved in energy metabolism and angiogenesis. The protein forms a complex by dimerizing with the HIF-1-beta subunit which is necessary for transcriptional activity. Through this complex formation and activity it influences processes such as erythropoiesis and regulates factors like vascular endothelial growth factor (VEGF). Therefore HIF-2-alpha contributes to the adaptation of cells and tissues under hypoxic conditions.
Pathways
HIF-2-alpha engages in the hypoxia signaling pathway playing an essential part by modulating gene expression in response to low oxygen availability. This role impacts other proteins such as HIF-1-alpha sharing overlapping functions but with distinct target genes. Additionally HIF-2-alpha is involved in the mTOR pathway which influences cell growth and metabolism through its interaction with the nutrient-sensing regulatory pathway.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Proceedings of the National Academy of Sciences of the United States of America 119:e2119854119 PubMed36037364
2022
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of 117:13023-13032 PubMed32461361
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer discovery 10:460-475 PubMed31810986
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncology research 26:1055-1062 PubMed29321085
2018
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 14:5643-5651 PubMed29098039
2017
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 33:1365-82 PubMed24837709
2014
Applications
ICC/IF, WB
Species
Unspecified reactive species, Unspecified reactive species
Journal of neurochemistry 129:400-12 PubMed24266789
2013
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com